サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566940

生体適合性コーティング市場：タイプ別、材料別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Biocompatible Coating Market By Type (Antimicrobial, Hydrophilic, Others) , By Material (Polymer, Ceramic, Metal, Others) By End User (Healthcare, Medical Device, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
生体適合性コーティング市場：タイプ別、材料別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生体適合コーティング市場は、2023年に134億米ドルと評価され、2024年から2033年にかけてCAGR 12%で成長し、2033年には414億米ドルに達すると予測されています。

生体適合性コーティングは、医療機器、インプラント、その他のヘルスケア関連材料に適用され、人体の生物学的環境との適合性を確保する生体材料です。これらのコーティングは、器具と周辺組織との調和のとれた相互作用を促進することで、炎症や拒絶反応などの副作用を最小限に抑えるように設計されています。防錆、耐摩耗、生物活性などの特性を付与することで医療用インプラントの性能と寿命を向上させ、医療技術の進歩と患者の転帰の改善に不可欠なものとなっています。

世界の生体適合性コーティング市場の成長は、老人人口の急増と慢性疾患の有病率の上昇によって、整形外科、歯科、心血管装置などの医療用インプラントのニーズが高まっていることが背景にあり、これらの医療用インプラントは、生体との安全かつ効果的な統合のために生体適合性コーティングを必要としています。さらに、感染症やインプラントの拒絶反応などの合併症リスクの低減が重視されるようになったことが、医療機器の安全性と適合性を向上させる生体適合性コーティングの採用を後押ししています。さらに、製薬セクターの拡大とドラッグデリバリーシステムに対する需要の急増は、医薬品有効成分の制御放出と安定性を確保するために生体適合性コーティングを必要としており、市場成長に寄与しています。さらに、医療用インプラントや医療機器に関連する感染症のリスクを低減するために、抗菌特性を備えた生体適合性コーティングを開発する傾向が強まっていることも、市場の成長を大きく促進しています。銀イオンやその他の抗菌剤を組み込んだこれらのコーティングは、術後の合併症を防ぐ上で極めて重要です。しかし、生体適合性コーティング、特にナノテクノロジーや生物活性物質のような先端材料を組み込んだコーティングの研究開発に伴う高コストが、市場成長の妨げとなっています。これは、生体適合性と耐久性を兼ね備えたコーティングの開発が技術的に困難であることに起因しています。安定した膜厚の確保、経時劣化の防止、所望の機能特性の実現といった問題は、特定のコーティングの拡張性や適用性を制限する可能性があります。その一方で、低侵襲手術の開発など、医療機器の設計と製造における技術革新は、これらの機器の性能と耐久性を高める高度な生体適合性コーティングの需要を促進しています。こうした発展は、予測期間中の市場成長に有利な機会を提供すると期待されています。

世界の生体適合コーティング産業は、タイプ、材料、エンドユーザー、地域に区分されます。タイプ別では、市場は抗菌性、親水性、その他に細分化されます。素材別では、ポリマー、セラミック、金属、その他に分けられます。エンドユーザー別では、ヘルスケア、医療機器、その他に分けられます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

タイプ別では、2024年から2033年にかけて抗菌コーティング分野が世界市場を独占すると予測されます。

材料別では、ポリマーが予測期間中に主要セグメントとして浮上すると予測されます。

エンドユーザー別では、医療機器分野が今後数年間で顕著な成長を示すと予測されています。

地域別では、北米が2023年に収益ベースで最大の市場シェアを占め、予測期間中も市場を独占すると予測されます。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 顧客の関心に応じた企業プロファイルの追加
  • 企業プロファイルの拡張リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 生体適合性コーティング市場：タイプ別

  • 市場概要
  • 抗菌性
  • 親水性
  • その他

第5章 生体適合性コーティング市場：材料別

  • 市場概要
  • ポリマー
  • セラミック
  • 金属
  • その他

第6章 生体適合性コーティング市場：エンドユーザー別

  • 市場概要
  • ヘルスケア
  • 医療機器
  • その他

第7章 生体適合性コーティング市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の生体適合性コーティング市場
    • カナダの生体適合性コーティング市場
    • メキシコの生体適合性コーティング市場
  • 欧州
    • 主な市場動向と機会
    • フランスの生体適合性コーティング市場
    • ドイツの生体適合性コーティング市場
    • イタリアの生体適合性コーティング市場
    • スペインの生体適合性コーティング市場
    • 英国の生体適合性コーティング市場
    • その他欧州の生体適合コーティング市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の生体適合性コーティング市場
    • 日本の生体適合性コーティング市場
    • インドの生体適合性コーティング市場
    • 韓国の生体適合性コーティング市場
    • オーストラリアの生体適合性コーティング市場
    • その他アジア太平洋の生体適合コーティング市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの生体適合性コーティング市場
    • 南アフリカの生体適合性コーティング市場
    • サウジアラビアの生体適合性コーティング市場
    • その他のラテンアメリカ・中東・アフリカの生体適合性コーティング市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • DSM Biomedical B.V.
  • Surmodics, Inc.
  • BASF SE
  • Covalon Technologies Ltd.
  • Harland Medical Systems, LLC
  • Biocoat, Inc.
  • BioInteractions Ltd.
  • AST Products, Inc.
  • PPG Industries
  • Precision Coating Company, Inc.
目次
Product Code: A323973

The biocompatible coating market was valued at $13.4 billion in 2023, and is projected to reach $41.4 billion by 2033, growing at a CAGR of 12% from 2024 to 2033.

Biocompatible coatings are biomaterials that are applied to medical devices, implants, and other healthcare-related materials to ensure they are compatible with the biological environment of the human body. These coatings are designed to minimize adverse reactions, such as inflammation or rejection, by promoting a harmonious interaction between the device and surrounding tissues. They enhance the performance and longevity of medical implants by imparting properties like anti-corrosion, anti-wear, and bioactivity, making them essential in advancing medical technology and improving patient outcomes.

The growth of the global biocompatible coating market is driven by surge in geriatric population and rise in prevalence of chronic diseases that are leading to increased need for medical implants, such as orthopedic, dental, and cardiovascular devices, which require biocompatible coatings for safe and effective integration with the body. According to the 2022 American Joint Replacement Registry (AJRR) annual report, approximately 2.8 million hip and knee procedures were carried out in the U.S. Moreover, rise in emphasis on reducing the risk of complications, such as infections and implant rejection, is driving the adoption of biocompatible coatings that improve the safety and compatibility of medical devices. Furthermore, the expansion of the pharmaceutical sector and surge in demand for drug delivery systems, which require biocompatible coatings to ensure controlled release and stability of active pharmaceutical ingredients, contribute toward the market growth. Moreover, the growing trend toward developing biocompatible coatings with antimicrobial properties to reduce the risk of infections associated with medical implants and devices is significantly fostering the market growth. These coatings, incorporating silver ions or other antimicrobial agents, are crucial in preventing postoperative complications. However, high cost associated with R&D of biocompatible coatings, especially those incorporating advanced materials like nanotechnology or bioactive substances, hampers the market growth. This is attributed to the fact that developing coatings that are both biocompatible and durable is technically challenging. Issues such as ensuring consistent coating thickness, preventing degradation over time, and achieving the desired functional properties can limit the scalability and applicability of certain coatings. On the contrary, innovations in medical device design and manufacturing, including the development of minimally invasive procedures, are driving the demand for advanced biocompatible coatings that enhance the performance and durability of these devices. Such developments are expected to offer lucrative opportunities for the market growth during the forecast period.

The global biocompatible coating industry is segmented into type, material, end user, and region. On the basis of type, the market is fragmented into antimicrobial, hydrophilic, and others. Depending on material, it is divided into polymer, ceramic, metal, and others. As per end user, it is segregated into healthcare, medical device, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the antimicrobial coatings segment is expected to dominate the global market from 2024 to 2033.

Depending on material, polymers is anticipated to emerge as a leading segment during the forecast period.

As per end user, the medical device segment is projected to exhibit notable growth in the coming years.

Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global biocompatible coating market include DSM Biomedical B.V., Surmodics, Inc., BASF SE, Covalon Technologies Ltd., Harland Medical Systems, LLC, Biocoat, Inc., BioInteractions Ltd., AST Products, Inc., PPG Industries, and Precision Coating Company, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Antimicrobial
  • Hydrophilic
  • Others

By Material

  • Polymer
  • Ceramic
  • Metal
  • Others

By End User

  • Healthcare
  • Medical Device
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • DSM Biomedical B.V.
    • Surmodics, Inc.
    • BASF SE
    • Covalon Technologies Ltd.
    • Harland Medical Systems, LLC
    • Biocoat, Inc.
    • BioInteractions Ltd.
    • AST Products, Inc.
    • PPG Industries
    • Precision Coating Company, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOCOMPATIBLE COATING MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Antimicrobial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Hydrophilic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOCOMPATIBLE COATING MARKET, BY MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Material
  • 5.2. Polymer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ceramic
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Metal
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOCOMPATIBLE COATING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Medical Device
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOCOMPATIBLE COATING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Biocompatible Coating Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Biocompatible Coating Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Biocompatible Coating Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Biocompatible Coating Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Biocompatible Coating Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Biocompatible Coating Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Biocompatible Coating Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Biocompatible Coating Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Biocompatible Coating Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Biocompatible Coating Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Biocompatible Coating Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Biocompatible Coating Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Biocompatible Coating Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Biocompatible Coating Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Biocompatible Coating Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Biocompatible Coating Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Biocompatible Coating Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Biocompatible Coating Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Biocompatible Coating Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. DSM Biomedical B.V.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Surmodics, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BASF SE
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Covalon Technologies Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Harland Medical Systems, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Biocoat, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BioInteractions Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. AST Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PPG Industries
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Precision Coating Company, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments